EP4178440A4 - KITS AND METHODS FOR MEASURING INSULIN SENSITIVITY - Google Patents

KITS AND METHODS FOR MEASURING INSULIN SENSITIVITY Download PDF

Info

Publication number: EP4178440A4
Authority: EP; European Patent Office
Prior art keywords: kits; methods; insulin sensitivity; measuring insulin; measuring
Prior art date: 2020-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP21838597.9A

Other languages

German (de)

French (fr)

Other versions

EP4178440A1 (en

Inventor

Eric RAVUSSIN

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Louisiana State University

Original Assignee

Louisiana State University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-07-10

Filing date

2021-07-12

Publication date

2024-10-30

2021-07-12 Application filed by Louisiana State University filed Critical Louisiana State University

2023-05-17 Publication of EP4178440A1 publication Critical patent/EP4178440A1/en

2024-10-30 Publication of EP4178440A4 publication Critical patent/EP4178440A4/en

Status Pending legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Pathology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Surgery (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Optics & Photonics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP21838597.9A 2020-07-10 2021-07-12 KITS AND METHODS FOR MEASURING INSULIN SENSITIVITY Pending EP4178440A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US202063050353P	2020-07-10	2020-07-10
PCT/US2021/041284 WO2022011345A1 (en)	2020-07-10	2021-07-12	Kits and methods for measuring insulin sensativity

Publications (2)

Publication Number	Publication Date
EP4178440A1 EP4178440A1 (en)	2023-05-17
EP4178440A4 true EP4178440A4 (en)	2024-10-30

Family

ID=79552128

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP21838597.9A Pending EP4178440A4 (en)	2020-07-10	2021-07-12	KITS AND METHODS FOR MEASURING INSULIN SENSITIVITY

Country Status (2)

Country	Link
EP (1)	EP4178440A4 (en)
WO (1)	WO2022011345A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089419A (en) *	1989-08-07	1992-02-18	International Canine Genetics	Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US20030028125A1 (en) *	2001-08-06	2003-02-06	Yuzhakov Vadim V.	Physiological sample collection devices and methods of using the same
US7725148B2 (en) *	2005-09-23	2010-05-25	Medtronic Minimed, Inc.	Sensor with layered electrodes
WO2007038670A2 (en) *	2005-09-30	2007-04-05	Perlegen Sciences, Inc.	Methods and compositions for screening and treatment of disorders of blood glucose regulation
GB2436873A (en) *	2006-04-07	2007-10-10	Univ Cambridge Tech	Blood glucose monitoring systems

2021
- 2021-07-12 EP EP21838597.9A patent/EP4178440A4/en active Pending
- 2021-07-12 WO PCT/US2021/041284 patent/WO2022011345A1/en not_active Ceased

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
F RELIMPIO ET AL: "Relationships of C-peptide levels and the C-peptide/bloodsugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients", DIABETES RESEARCH AND CLINICAL PRACTICE, vol. 36, no. 3, 1 June 1997 (1997-06-01), NL, pages 173 - 180, XP055126900, ISSN: 0168-8227, DOI: 10.1016/S0168-8227(97)00049-1 *
G�BOR WINKLER ET AL: "Tumor necrosis factor system in insulin resistance in gestational diabetes", DIABETES RESEARCH AND CLINICAL PRACTICE, vol. 56, no. 2, 1 May 2002 (2002-05-01), NL, pages 93 - 99, XP055524804, ISSN: 0168-8227, DOI: 10.1016/S0168-8227(01)00355-2 *
PALIK ET AL: "Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance", DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, vol. 76, no. 3, 29 March 2007 (2007-03-29), pages 351 - 357, XP022003401, ISSN: 0168-8227, DOI: 10.1016/J.DIABRES.2006.09.005 *
SAISHO YOSHIFUMI: "Postprandial C-Peptide to Glucose Ratio as a Marker of [beta] Cell Function: Implication for the Management of Type 2 Diabetes", vol. 17, no. 5, 17 May 2016 (2016-05-17), Basel, CH, pages 744, XP093203296, ISSN: 1422-0067, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881566/pdf/ijms-17-00744.pdf> DOI: 10.3390/ijms17050744 *
See also references of WO2022011345A1 *
STEINER J ET AL: "Elevated S100B levels in schizophrenia are associated with insulin resistance", MOLECULAR PSYCHIATRY, NATURE PUBLISHING GROUP UK, LONDON, vol. 15, no. 1, 22 December 2009 (2009-12-22), pages 3 - 4, XP037791370, ISSN: 1359-4184, [retrieved on 20091222], DOI: 10.1038/MP.2009.87 *

Also Published As

Publication number	Publication date
EP4178440A1 (en)	2023-05-17
WO2022011345A1 (en)	2022-01-13

Publication	Publication Date	Title
EP4305196C0 (en)	2025-04-02	METHOD FOR MEASURING ANALYTE MISLOCALIZATION
EP4057562C0 (en)	2025-08-20	METHOD AND DEVICE FOR MEASURING THE CONFIGURATION OF DIFFERENT REFERENCE SIGNALS AND CELL MEASUREMENT REPORTING MECHANISM
EP4039178C0 (en)	2025-04-09	MEASURING DEVICE AND METHOD FOR MEASURING CHANGES IN CHROMOPHORE CONCENTRATION
EP3755226C0 (en)	2023-12-27	SYSTEM AND METHOD FOR DETECTING AND MEASURING AFFECTIVE STATES
EP4143590A4 (en)	2023-11-08	INTEGRATED MEASURING SYSTEMS AND METHODS FOR SYNCHRONOUS ACCURATE MEASUREMENT OF MATERIAL PROPERTIES
EP3596448A4 (en)	2020-12-23	METHODS FOR IMPROVING USABILITY AND ACCURACY FOR PHYSIOLOGICAL MEASUREMENT
EP3922992A4 (en)	2022-05-11	KIT FOR MEASUREMENT OF AN ANALYTE AND PROCEDURE FOR DETERMINATION OF AN ANALYTE
EP3942568A4 (en)	2022-11-30	SYSTEM AND METHOD FOR AUTOMATIC MEASUREMENT OF EVOTED POTENTIAL
EP3526560A4 (en)	2020-07-08	DEVICE AND METHOD FOR MEASURING THE SPECTRES OF A LIQUID SAMPLE USING AN INTEGRATING CAVITY
EP3623847A4 (en)	2020-12-09	PET DEVICE WITH FUNCTION FOR POSITRON LIFE MEASUREMENT AND METHOD OF MEASURING POSITRON LIFE IN A PET DEVICE
EP3857235C0 (en)	2025-09-10	METHOD FOR MEASURING ANTIBODY DYNAMICS
EP4425181A4 (en)	2025-09-24	COMPOSITION FOR DETECTING OR MEASURING AN ANALYTE
EP3891479C0 (en)	2025-11-19	METHOD AND DEVICE FOR MEASURING LIGHT INTENSITY FOR IMAGERATION
EP4049920A4 (en)	2022-12-28	METHOD OF MEASUREMENT OF FLATNESS AND DISTANCE OF VEHICLE PARTS AND MEASURING TUNNEL
EP4260027C0 (en)	2025-11-12	SYSTEM AND METHOD FOR MEASURING THE COLOR OF A SAMPLE AREA
EP3805694A4 (en)	2022-03-02	LIQUID FILM THICKNESS MEASUREMENT METHOD, MEASURING DEVICE, FILM MAKING METHOD
EP4134675A4 (en)	2024-01-17	METHOD FOR MEASURING BLOOD CLOTTING TIME
EP3835792C0 (en)	2024-06-12	ACCELERATION SENSOR AND METHODS FOR MEASURING ACCELERATION DATA
EP4016060A4 (en)	2023-07-26	OPTICAL CONSTANT MEASUREMENT DEVICE, OPTICAL CONSTANT MEASUREMENT METHOD AND OPTICAL CONSTANT CALCULATION METHOD
EP4560531A4 (en)	2025-11-26	METHOD AND DEVICE FOR MEASURING DATA QUALITY
EP4538654A4 (en)	2025-09-24	DEVICE FOR MEASURING PHYSICAL QUANTITIES
EP4215110A4 (en)	2024-03-20	METHOD AND DEVICE FOR MEASURING BODY COMPOSITION
EP4277335A4 (en)	2024-06-19	METHOD AND DEVICE FOR MEASURING BEAM QUALITY
EP3869149C0 (en)	2025-04-30	DEVICE AND METHOD FOR MEASURING SURFACES
EP4178440A4 (en)	2024-10-30	KITS AND METHODS FOR MEASURING INSULIN SENSITIVITY

Legal Events

Date	Code	Title	Description
2022-01-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2023-04-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2023-04-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2023-05-17	17P	Request for examination filed	Effective date: 20230208
2023-05-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2023-10-18	DAV	Request for validation of the european patent (deleted)
2023-10-18	DAX	Request for extension of the european patent (deleted)
2024-10-30	A4	Supplementary search report drawn up and despatched	Effective date: 20240927
2024-10-30	RIC1	Information provided on ipc code assigned before grant	Ipc: G01N 33/68 20060101ALI20240923BHEP Ipc: G01N 33/66 20060101ALI20240923BHEP Ipc: A61B 5/145 20060101AFI20240923BHEP
2025-05-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2025-06-11	17Q	First examination report despatched	Effective date: 20250512